Furthermore, we established stable METTL14 knockdown in luciferase-expressing OSRC-2 cells to investigate the anti-metastatic effect of METTL14 in ccRCC in vivo. The gene discussed is METTL14; the disease is nonpapillary renal cell carcinoma.